Shanghai RAAS Blood Products Co., Ltd.
002252
Rank in Stocks
#3629
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Share Price
$0.70862889
Market Cap
$4.67B
Change (1 day)
0.62%
Change (1 year)
-24.17%
Country
CN
Trade Shanghai RAAS Blood Products Co., Ltd. (002252)
Category
Healthcare
EPS for Shanghai RAAS Blood Products Co., Ltd. (002252)
EPS as of June 2026 TTM: $0.03
According to Shanghai RAAS Blood Products Co., Ltd. latest financial reports and stock price the company's current EPS (TTM) is $0.03. At the end of 2023 the company had a EPS of $0.04 equal to its 2022 EPS that were of $0.04.
EPS history for Shanghai RAAS Blood Products Co., Ltd. from 2005 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.03 | -47.80% |
| 2024 | $0.05 | 18.64% |
| 2023 | $0.04 | -6.16% |
| 2022 | $0.04 | 34.44% |
| 2021 | $0.03 | 0.33% |
| 2020 | $0.03 | 75.00% |
| 2019 | $0.02 | -138.14% |
| 2018 | $-0.05 | -272.80% |
| 2017 | $0.03 | -45.05% |
| 2016 | $0.05 | 6.26% |
| 2015 | $0.04 | 130.41% |
| 2014 | $0.02 | 203.13% |
| 2013 | $0.01 | -37.25% |
| 2012 | $0.01 | 12.09% |
| 2011 | $0.01 | 13.75% |
| 2010 | $0.01 | 40.35% |
| 2009 | $0.01 | 14.00% |
| 2008 | $0.01 | 19.05% |
| 2007 | 0.00 | -38.24% |
| 2006 | $0.01 | 3.03% |
| 2005 | $0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $17.32 | 66,260.15% |
US
|
|
| $-7.98 | -30,674.71% |
US
|
|
| $-5.29 | -20,368.20% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 106,183.52% |
NL
|
